Is Ozempic (Semaglutide) Right For Me?
Apr 25, 2022•40 min•Season 1Ep. 115
Episode description
Health Canada recently approved a new weight loss drug, semaglutide, also known as “Ozempic” or “Wegovy.” Experts refer to it as a “game changer” for its ability to curtail appetite and spur weight loss. In this episode, Medcan’s director of weight management, Dr. David Macklin, a co-author of Canada’s national guidelines for obesity treatment, provides host Shaun Francis with a semaglutide explainer. “We’re in a super exciting stage in my field of medicine,” Dr. Macklin says.
Check out episode highlights and links on our webpage.
For the best experience, listen in Metacast app for iOS or Android
